Quarterly report pursuant to Section 13 or 15(d)

Revenues (Narrative) (Details)

v3.10.0.1
Revenues (Narrative) (Details) - USD ($)
9 Months Ended 12 Months Ended
May 31, 2018
Aug. 31, 2017
Earned revenue $ 17,083 $ 30,317
Licensing fees $ 304,600  
Cannfections Group Inc. [Member]    
Licensing fees, term of contract 7 years  
NeutriSci International Inc. [Member]    
Licensing fees, term of contract 2 years  
Biolog, Inc. [Member]    
Licensing fees, term of contract 5 years  
GP Holdings LLC [Member]    
Licensing fees, term of contract 5 years  
Nuka Enterprises LLC [Member]    
Licensing fees, term of contract 10 years  
Nuka Enterprises LLC - Chocolate only [Member]    
Licensing fees, term of contract 2 years